<p>The object aims to inhibit the transcriptional activity of the TCF/LEF family to prevent or treat cancer. Disclosed is a method for the screening of an anti-cancer agent, which is characterized by selecting a compound capable of inhibiting the kinase activity of TNIK (TRAF2 and NCK interacting kinase) or selecting a compound capable of inhibiting the binding between TNIK and a ß-catenin/TCF4 transcription complex.</p>
申请公布号
WO2009104413(A1)
申请公布日期
2009.08.27
申请号
WO2009JP00737
申请日期
2009.02.20
申请人
JAPAN HEALTH SCIENCES FOUNDATION;YAMADA, TESSHI;SHITASHIGE, MIKI;HIROHASHI, SETSUO